Inhibition or genetic reduction of ASAH1/acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson's patients. [PDF]
Kumar M, Feldman RA.
europepmc +1 more source
The genetic architecture of Parkinson's disease on the Island of Crete. [PDF]
Boura I +13 more
europepmc +1 more source
Two lysosomal genes ATP13A2 and GBA1 interact to drive neurodegeneration. [PDF]
Gu M +17 more
europepmc +1 more source
Plasma Levels of Food-Derived Metabolites as Biomarkers of Parkinson's Disease. [PDF]
Dong X +7 more
europepmc +1 more source
Early Diagnosis of Gaucher Disease and ASMD in Sardinia: The "Ichnos" Project. [PDF]
Costa A +10 more
europepmc +1 more source
Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype. [PDF]
Cullufi P +8 more
europepmc +1 more source
N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models. [PDF]
Song P +12 more
europepmc +1 more source
The genetic architecture of Parkinson's disease in Mexico: a systematic review. [PDF]
Arias-Carrión O +4 more
europepmc +1 more source
Dairy-rich diet triggers hepatic α-synuclein pathology via the liver-brain axis in GBA1-related Parkinson's disease. [PDF]
Chen Y +12 more
europepmc +1 more source
A guide to selecting high-performing antibodies for GCase (UniProt ID: P04062) for use in western blot, immunoprecipitation, and immunofluorescence. [PDF]
Worrall D +8 more
europepmc +1 more source

